Hisayuki Yokoyama

Yamagata, 9909585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Recent advances in cell therapy for AML/MDS.

Recent advances in cell therapy for AML/MDS.

Journal: International journal of hematology

Published: August 18, 2026

Timing of response in patients with relapsed/refractory FLT3 mut+ acute myeloid leukemia treated with gilteritinib.

Timing of response in patients with relapsed/refractory FLT3 mut+ acute myeloid leukemia treated with gilteritinib.

Journal: Blood neoplasia

Published: February 19, 2026

The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis.

The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis.

Journal: Transplantation proceedings

Published: January 23, 2026

Splenic rupture secondary to pegfilgrastim in a healthy allogeneic peripheral blood hematopoietic stem cell donor.

Splenic rupture secondary to pegfilgrastim in a healthy allogeneic peripheral blood hematopoietic stem cell donor.

Journal: International journal of hematology

Published: January 13, 2026

Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation.

Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation.

Journal: Experimental hematology

Published: January 08, 2026

Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study.

Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 14, 2025

NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway.

NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway.

Journal: Haematologica

Published: September 13, 2025

Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.

Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.

Journal: Journal of patient-reported outcomes

Published: July 23, 2025

Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.

Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.

Journal: Blood advances

Published: June 30, 2025

High FCGR2B Expression Can Identify Low-tumor-burden Follicular Lymphoma Patients Who Do Not Require Any Antilymphoma Therapy for a Long Term.

High FCGR2B Expression Can Identify Low-tumor-burden Follicular Lymphoma Patients Who Do Not Require Any Antilymphoma Therapy for a Long Term.

Journal: The American journal of surgical pathology

Published: April 07, 2025

Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type.

Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type.

Journal: Annals of hematology

Published: January 21, 2025

Successful Allogeneic Hematopoietic Stem Cell Transplantation for Nodal Epstein-Barr Virus-positive T/NK-cell Lymphoma.

Successful Allogeneic Hematopoietic Stem Cell Transplantation for Nodal Epstein-Barr Virus-positive T/NK-cell Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: November 20, 2024

Showing 1-12 of 115

Last Updated: 09/26/2026